{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T14:15:32Z","timestamp":1775830532654,"version":"3.50.1"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The rarity and heterogeneity of adult-onset Still\u2019s disease (AOSD) pose significant challenges in understanding its precise pathogenic mechanisms, developing effective treatment options, and establishing therapeutic strategies. A comprehensive analysis of gene expression profiles could help to bridge the knowledge gaps in those areas.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A blood transcriptomic dataset comprising 31 patients with AOSD and 22 healthy controls was fetched. Cellular and molecular features were identified by analyzing differentially expressed genes (DEGs) and functional enrichment. Optimal molecular targets for neutrophil activation were identified using kernel-based diffusion scoring techniques.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Blood molecular signatures indicate that neutrophil degranulation is the most enriched pathological process in AOSD. Neutrophil degranulation correlated significantly with the expression of Fc\u03b3 receptors, IL-1 receptors, and chemokine receptors and their signaling activities. IL-1 inhibitors and IL-6 inhibitors did not exhibit a diffusion score favorable for directly deactivating neutrophil degranulation, but agents targeting CXCR1\/CXCR2, C5AR1, neutrophil elastase, SRC, and SYK demonstrated significant diffusion scores for neutrophil degranulation. In particular, CXCR1, CXCR2, and C5AR1 were the DEGs predominantly expressed in neutrophils and closely associated with neutrophil degranulation in a context-specific functional analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Neutrophil activation is a key pathological module in AOSD. Therapeutic approaches aimed at neutrophils could offer a promising opportunity to regulate the inflammatory response in AOSD.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13075-025-03598-5","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T09:08:40Z","timestamp":1751360920000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Targeting neutrophil-driven inflammation in adult-onset still\u2019s disease: molecular insights from gene expression profiles"],"prefix":"10.1186","volume":"27","author":[{"given":"In-Woon","family":"Baek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyoun-Ah","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung-Su","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ki-Jo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"issue":"4","key":"3598_CR1","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.semarthrit.2021.06.004","volume":"51","author":"P Efthimiou","year":"2021","unstructured":"Efthimiou P, Kontzias A, Hur P, Rodha K, Ramakrishna GS, Nakasato P. Adult-onset still\u2019s disease in focus: clinical manifestations, diagnosis, treatment, and unmet needs in the era of targeted therapies. Semin Arthritis Rheum. 2021;51(4):858\u201374.","journal-title":"Semin Arthritis Rheum"},{"key":"3598_CR2","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jaut.2018.07.018","volume":"93","author":"R Giacomelli","year":"2018","unstructured":"Giacomelli R, Ruscitti P, Shoenfeld Y. A comprehensive review on adult onset still\u2019s disease. J Autoimmun. 2018;93:24\u201336.","journal-title":"J Autoimmun"},{"issue":"1\u20132","key":"3598_CR3","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s12026-014-8561-9","volume":"61","author":"Y Jamilloux","year":"2015","unstructured":"Jamilloux Y, Gerfaud-Valentin M, Martinon F, Belot A, Henry T, S\u00e8ve P. Pathogenesis of adult-onset still\u2019s disease: new insights from the juvenile counterpart. Immunol Res. 2015;61(1\u20132):53\u201362.","journal-title":"Immunol Res"},{"issue":"10","key":"3598_CR4","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/s41584-018-0081-x","volume":"14","author":"E Feist","year":"2018","unstructured":"Feist E, Mitrovic S, Fautrel B. Mechanisms, biomarkers and targets for adult-onset still\u2019s disease. Nat Rev Rheumatol. 2018;14(10):603\u201318.","journal-title":"Nat Rev Rheumatol"},{"issue":"8","key":"3598_CR5","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1002\/art.27532","volume":"62","author":"S Franchini","year":"2010","unstructured":"Franchini S, Dagna L, Salvo F, Aiello P, Baldissera E, Sabbadini MG. Efficacy of traditional and biologic agents in different clinical phenotypes of adult-onset still\u2019s disease. Arthritis Rheum. 2010;62(8):2530\u20135.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"3598_CR6","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.berh.2016.08.003","volume":"30","author":"S Casta\u00f1eda","year":"2016","unstructured":"Casta\u00f1eda S, Blanco R, Gonz\u00e1lez-Gay MA. Adult-onset still\u2019s disease: advances in the treatment. Best Pract Res Clin Rheumatol. 2016;30(2):222\u201338.","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"6","key":"3598_CR7","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1093\/rheumatology\/kead461","volume":"63","author":"HL Leavis","year":"2024","unstructured":"Leavis HL, van Daele PLA, Mulders-Manders C, et al. Management of adult-onset still\u2019s disease: evidence- and consensus-based recommendations by experts. Rheumatology (Oxford). 2024;63(6):1656\u201363.","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"3598_CR8","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s40265-024-01993-x","volume":"84","author":"S Bindoli","year":"2024","unstructured":"Bindoli S, Baggio C, Doria A, Sfriso P. Adult-Onset still\u2019s disease (AOSD): advances in Understanding pathophysiology, genetics and emerging treatment options. Drugs. 2024;84(3):257\u201374.","journal-title":"Drugs"},{"issue":"1","key":"3598_CR9","doi-asserted-by":"publisher","first-page":"4385","DOI":"10.1038\/s41467-021-24584-w","volume":"12","author":"MC Altman","year":"2021","unstructured":"Altman MC, Rinchai D, Baldwin N, et al. Development of a fixed module repertoire for the analysis and interpretation of blood transcriptome data. Nat Commun. 2021;12(1):4385.","journal-title":"Nat Commun"},{"issue":"7309","key":"3598_CR10","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1038\/nature09247","volume":"466","author":"MP Berry","year":"2010","unstructured":"Berry MP, Graham CM, McNab FW, et al. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature. 2010;466(7309):973\u20137.","journal-title":"Nature"},{"issue":"4","key":"3598_CR11","doi-asserted-by":"publisher","first-page":"e122312","DOI":"10.1172\/jci.insight.122312","volume":"5","author":"WA Haynes","year":"2020","unstructured":"Haynes WA, Haddon DJ, Diep VK, et al. Integrated, multicohort analysis reveals unified signature of systemic lupus erythematosus. JCI Insight. 2020;5(4):e122312.","journal-title":"JCI Insight"},{"issue":"25","key":"3598_CR12","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1056\/NEJMoa1205099","volume":"367","author":"N Ruperto","year":"2012","unstructured":"Ruperto N, Brunner HI, Quartier P, et al. Two randomized trials of Canakinumab in systemic juvenile idiopathic arthritis. N Engl J Med. 2012;367(25):2396\u2013406.","journal-title":"N Engl J Med"},{"issue":"1","key":"3598_CR13","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13075-016-1212-x","volume":"19","author":"AH Brachat","year":"2017","unstructured":"Brachat AH, Grom AA, Wulffraat N, et al. Early changes in gene expression and inflammatory proteins in systemic juvenile idiopathic arthritis patients on Canakinumab therapy. Arthritis Res Ther. 2017;19(1):13.","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"3598_CR14","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1093\/bioinformatics\/btg405","volume":"20","author":"L Gautier","year":"2004","unstructured":"Gautier L, Cope L, Bolstad BM, Irizarry RA. affy\u2013analysis of affymetrix genechip data at the probe level. Bioinformatics. 2004;20(3):307\u201315.","journal-title":"Bioinformatics"},{"issue":"13","key":"3598_CR15","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1093\/bioinformatics\/btn224","volume":"24","author":"P Du","year":"2008","unstructured":"Du P, Kibbe WA, Lin SM. Lumi: a pipeline for processing illumina microarray. Bioinformatics. 2008;24(13):1547\u20138.","journal-title":"Bioinformatics"},{"issue":"1","key":"3598_CR16","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1093\/biostatistics\/kxj037","volume":"8","author":"WE Johnson","year":"2007","unstructured":"Johnson WE, Li C, Rabinovic A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics. 2007;8(1):118\u201327.","journal-title":"Biostatistics"},{"issue":"2","key":"3598_CR17","doi-asserted-by":"publisher","first-page":"e17238","DOI":"10.1371\/journal.pone.0017238","volume":"6","author":"C Chen","year":"2011","unstructured":"Chen C, Grennan K, Badner J, et al. Removing batch effects in analysis of expression microarray data: an evaluation of six batch adjustment methods. PLoS ONE. 2011;6(2):e17238.","journal-title":"PLoS ONE"},{"issue":"6","key":"3598_CR18","doi-asserted-by":"publisher","first-page":"e0156594","DOI":"10.1371\/journal.pone.0156594","volume":"11","author":"C M\u00fcller","year":"2016","unstructured":"M\u00fcller C, Schillert A, R\u00f6themeier C, et al. Removing batch effects from longitudinal gene Expression - Quantile normalization plus combat as best approach for microarray transcriptome data. PLoS ONE. 2016;11(6):e0156594.","journal-title":"PLoS ONE"},{"issue":"7","key":"3598_CR19","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47.","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"3598_CR20","doi-asserted-by":"publisher","first-page":"W168","DOI":"10.1093\/nar\/gkad393","volume":"51","author":"JE Evangelista","year":"2023","unstructured":"Evangelista JE, Xie Z, Marino GB, Nguyen N, Clarke DJB. Ma\u2019ayan A. Enrichr-KG: bridging enrichment analysis across multiple libraries. Nucleic Acids Res. 2023;51(W1):W168\u201379.","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"3598_CR21","doi-asserted-by":"publisher","first-page":"e13984","DOI":"10.1371\/journal.pone.0013984","volume":"5","author":"D Merico","year":"2010","unstructured":"Merico D, Isserlin R, Stueker O, Emili A, Bader GD. Enrichment map: a network-based method for gene-set enrichment visualization and interpretation. PLoS ONE. 2010;5(11):e13984.","journal-title":"PLoS ONE"},{"issue":"43","key":"3598_CR22","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545\u201350.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"D1","key":"3598_CR23","doi-asserted-by":"publisher","first-page":"D353","DOI":"10.1093\/nar\/gkw1092","volume":"45","author":"M Kanehisa","year":"2017","unstructured":"Kanehisa M, Furumichi M, Tanabe M, Sato Y, Morishima K. KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 2017;45(D1):D353\u201361.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"3598_CR24","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner M, Ball CA, Blake JA, et al. Gene ontology: tool for the unification of biology. The gene ontology consortium. Nat Genet. 2000;25(1):25\u20139.","journal-title":"Nat Genet"},{"issue":"D1","key":"3598_CR25","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkad1025","volume":"52","author":"M Milacic","year":"2024","unstructured":"Milacic M, Beavers D, Conley P, et al. The reactome pathway knowledgebase 2024. Nucleic Acids Res. 2024;52(D1):D672\u20138.","journal-title":"Nucleic Acids Res"},{"key":"3598_CR26","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics. 2013;14:7.","journal-title":"BMC Bioinformatics"},{"issue":"16","key":"3598_CR27","first-page":"2382","volume":"37","author":"D Rinchai","year":"2021","unstructured":"Rinchai D, Roelands J, Toufiq M, et al. BloodGen3Module: blood transcriptional module repertoire analysis and visualization using. R Bioinf. 2021;37(16):2382\u20139.","journal-title":"R Bioinf"},{"key":"3598_CR28","doi-asserted-by":"crossref","unstructured":"Angel A, Naom L, Nabet-Levy S, Aran D. xCell 2.0: robust algorithm for cell type proportion Estimation predicts response to immune checkpoint Blockade. bioRxiv 2024:2024.09.06.611424.","DOI":"10.1101\/2024.09.06.611424"},{"key":"3598_CR29","doi-asserted-by":"publisher","first-page":"103477","DOI":"10.1016\/j.ebiom.2021.103477","volume":"70","author":"Y Deng","year":"2021","unstructured":"Deng Y, Zheng Y, Li D, et al. Expression characteristics of interferon-stimulated genes and possible regulatory mechanisms in lupus patients using transcriptomics analyses. EBioMedicine. 2021;70:103477.","journal-title":"EBioMedicine"},{"issue":"6","key":"3598_CR30","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon A, Birger C, Thorvaldsd\u00f3ttir H, Ghandi M, Mesirov JP, Tamayo P. The molecular signatures database (MSigDB) hallmark gene set collection. Cell Syst. 2015;1(6):417\u201325.","journal-title":"Cell Syst"},{"issue":"35","key":"3598_CR31","doi-asserted-by":"publisher","first-page":"eadg6375","DOI":"10.1126\/sciadv.adg6375","volume":"9","author":"J Guthrie","year":"2023","unstructured":"Guthrie J, K\u00f6stel Bal S, Lombardo SD, et al. AutoCore: A network-based definition of the core module of human autoimmunity and autoinflammation. Sci Adv. 2023;9(35):eadg6375.","journal-title":"Sci Adv"},{"issue":"5","key":"3598_CR32","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1145\/324133.324140","volume":"46","author":"JM Kleinberg","year":"1999","unstructured":"Kleinberg JM. Authoritative sources in a hyperlinked environment. J ACM. 1999;46(5):604\u201332.","journal-title":"J ACM"},{"issue":"3","key":"3598_CR33","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1093\/bioinformatics\/btx632","volume":"34","author":"S Picart-Armada","year":"2018","unstructured":"Picart-Armada S, Thompson WK, Buil A, Perera-Lluna A. DiffuStats: an R package to compute diffusion-based scores on biological networks. Bioinformatics. 2018;34(3):533\u20134.","journal-title":"Bioinformatics"},{"issue":"D1","key":"3598_CR34","doi-asserted-by":"publisher","first-page":"D1265","DOI":"10.1093\/nar\/gkad976","volume":"52","author":"C Knox","year":"2024","unstructured":"Knox C, Wilson M, Klinger CM, et al. DrugBank 6.0: the drugbank knowledgebase for 2024. Nucleic Acids Res. 2024;52(D1):D1265\u201375.","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"3598_CR35","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1038\/s41590-020-0736-z","volume":"21","author":"X Xie","year":"2020","unstructured":"Xie X, Shi Q, Wu P, et al. Single-cell transcriptome profiling reveals neutrophil heterogeneity in homeostasis and infection. Nat Immunol. 2020;21(9):1119\u201333.","journal-title":"Nat Immunol"},{"issue":"13","key":"3598_CR36","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao Y, Hao S, Andersen-Nissen E, et al. Integrated analysis of multimodal single-cell data. Cell. 2021;184(13):3573\u2013e8729.","journal-title":"Cell"},{"issue":"2","key":"3598_CR37","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41590-018-0276-y","volume":"20","author":"D Aran","year":"2019","unstructured":"Aran D, Looney AP, Liu L, et al. Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage. Nat Immunol. 2019;20(2):163\u201372.","journal-title":"Nat Immunol"},{"issue":"3","key":"3598_CR38","doi-asserted-by":"publisher","first-page":"e1012278","DOI":"10.1371\/journal.pcbi.1012278","volume":"21","author":"S Zehr","year":"2025","unstructured":"Zehr S, Wolf S, Oellerich T, et al. GeneCOCOA: detecting context-specific functions of individual genes using co-expression data. PLoS Comput Biol. 2025;21(3):e1012278.","journal-title":"PLoS Comput Biol"},{"issue":"4","key":"3598_CR39","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nrrheum.2018.31","volume":"14","author":"TLW Muskardin","year":"2018","unstructured":"Muskardin TLW, Niewold TB. Type I interferon in rheumatic diseases. Nat Rev Rheumatol. 2018;14(4):214\u201328.","journal-title":"Nat Rev Rheumatol"},{"key":"3598_CR40","doi-asserted-by":"crossref","unstructured":"Rodr\u00edguez-Carrio J, Burska A, Conaghan PG et al. Association between type I interferon pathway activation and clinical outcomes in rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider. RMD Open 2023;9(1).","DOI":"10.1136\/rmdopen-2022-002864"},{"key":"3598_CR41","doi-asserted-by":"publisher","first-page":"46652","DOI":"10.1038\/srep46652","volume":"7","author":"JH Han","year":"2017","unstructured":"Han JH, Suh CH, Jung JY, et al. Elevated Circulating levels of the interferon-\u03b3-induced chemokines are associated with disease activity and cutaneous manifestations in adult-onset still\u2019s disease. Sci Rep. 2017;7:46652.","journal-title":"Sci Rep"},{"key":"3598_CR42","doi-asserted-by":"publisher","first-page":"102793","DOI":"10.1016\/j.jaut.2022.102793","volume":"127","author":"Y Ma","year":"2022","unstructured":"Ma Y, Wang M, Jia J, et al. Enhanced type I interferon signature induces neutrophil extracellular traps enriched in mitochondrial DNA in adult-onset still\u2019s disease. J Autoimmun. 2022;127:102793.","journal-title":"J Autoimmun"},{"issue":"1","key":"3598_CR43","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13075-025-03498-8","volume":"27","author":"IW Baek","year":"2025","unstructured":"Baek IW, Rhim JW, Park KS, Kim KJ. Blood molecular subtypes to guide precision treatment strategies in systemic juvenile idiopathic arthritis. Arthritis Res Ther. 2025;27(1):27.","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"3598_CR44","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/nrrheum.2016.166","volume":"12","author":"G Schett","year":"2016","unstructured":"Schett G, Dayer JM, Manger B. Interleukin-1 function and role in rheumatic disease. Nat Rev Rheumatol. 2016;12(1):14\u201324.","journal-title":"Nat Rev Rheumatol"},{"issue":"10","key":"3598_CR45","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/s41584-019-0277-8","volume":"15","author":"CA Dinarello","year":"2019","unstructured":"Dinarello CA. The IL-1 family of cytokines and receptors in rheumatic diseases. Nat Rev Rheumatol. 2019;15(10):612\u201332.","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"3598_CR46","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.immuni.2019.03.012","volume":"50","author":"A Mantovani","year":"2019","unstructured":"Mantovani A, Dinarello CA, Molgora M, Garlanda C. Interleukin-1 and related cytokines in the regulation of inflammation and immunity. Immunity. 2019;50(4):778\u201395.","journal-title":"Immunity"},{"issue":"4","key":"3598_CR47","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/s41573-019-0054-z","volume":"19","author":"T N\u00e9meth","year":"2020","unstructured":"N\u00e9meth T, Sperandio M, M\u00f3csai A. Neutrophils as emerging therapeutic targets. Nat Rev Drug Discov. 2020;19(4):253\u201375.","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"3598_CR48","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/nrg2918","volume":"12","author":"AL Barab\u00e1si","year":"2011","unstructured":"Barab\u00e1si AL, Gulbahce N, Loscalzo J. Network medicine: a network-based approach to human disease. Nat Rev Genet. 2011;12(1):56\u201368.","journal-title":"Nat Rev Genet"},{"issue":"7","key":"3598_CR49","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1039\/c3mb25438k","volume":"9","author":"G Laenen","year":"2013","unstructured":"Laenen G, Thorrez L, B\u00f6rnigen D, Moreau Y. Finding the targets of a drug by integration of gene expression data with a protein interaction network. Mol Biosyst. 2013;9(7):1676\u201385.","journal-title":"Mol Biosyst"},{"issue":"Suppl","key":"3598_CR50","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1016\/j.drudis.2011.12.008","volume":"17","author":"I Gashaw","year":"2012","unstructured":"Gashaw I, Ellinghaus P, Sommer A, Asadullah K. What makes a good drug target? Drug Discov Today. 2012;17(Suppl):S24\u201330.","journal-title":"Drug Discov Today"},{"key":"3598_CR51","doi-asserted-by":"crossref","unstructured":"Uhlen M, Karlsson MJ, Zhong W et al. A genome-wide transcriptomic analysis of protein-coding genes in human blood cells. Science 2019;366(6472).","DOI":"10.1126\/science.aax9198"},{"issue":"12","key":"3598_CR52","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.3899\/jrheum.181058","volume":"46","author":"MH Ahn","year":"2019","unstructured":"Ahn MH, Han JH, Chwae YJ, et al. Neutrophil extracellular traps May contribute to the pathogenesis in Adult-onset still disease. J Rheumatol. 2019;46(12):1560\u20139.","journal-title":"J Rheumatol"},{"issue":"2","key":"3598_CR53","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s41423-021-00832-3","volume":"19","author":"A Herrero-Cervera","year":"2022","unstructured":"Herrero-Cervera A, Soehnlein O, Kenne E. Neutrophils in chronic inflammatory diseases. Cell Mol Immunol. 2022;19(2):177\u201391.","journal-title":"Cell Mol Immunol"},{"issue":"4","key":"3598_CR54","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nri.2017.10","volume":"17","author":"O Soehnlein","year":"2017","unstructured":"Soehnlein O, Steffens S, Hidalgo A, Weber C. Neutrophils as protagonists and targets in chronic inflammation. Nat Rev Immunol. 2017;17(4):248\u201361.","journal-title":"Nat Rev Immunol"},{"key":"3598_CR55","doi-asserted-by":"publisher","first-page":"508","DOI":"10.3389\/fimmu.2014.00508","volume":"5","author":"C Tecchio","year":"2014","unstructured":"Tecchio C, Micheletti A, Cassatella MA. Neutrophil-derived cytokines: facts beyond expression. Front Immunol. 2014;5:508.","journal-title":"Front Immunol"},{"issue":"Suppl 2","key":"3598_CR56","doi-asserted-by":"publisher","first-page":"e12952","DOI":"10.1111\/eci.12952","volume":"48","author":"N Tamassia","year":"2018","unstructured":"Tamassia N, Bianchetto-Aguilera F, Arruda-Silva F, et al. Cytokine production by human neutrophils: revisiting the dark side of the Moon. Eur J Clin Invest. 2018;48(Suppl 2):e12952.","journal-title":"Eur J Clin Invest"},{"issue":"12","key":"3598_CR57","doi-asserted-by":"publisher","first-page":"e13028","DOI":"10.1111\/eci.13028","volume":"48","author":"AJT Wood","year":"2018","unstructured":"Wood AJT, Vassallo A, Summers C, Chilvers ER, Conway-Morris A. C5a anaphylatoxin and its role in critical illness-induced organ dysfunction. Eur J Clin Invest. 2018;48(12):e13028.","journal-title":"Eur J Clin Invest"},{"issue":"8","key":"3598_CR58","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1136\/annrheumdis-2020-217155","volume":"79","author":"C Kedor","year":"2020","unstructured":"Kedor C, Listing J, Zernicke J, et al. Canakinumab for treatment of Adult-Onset still\u2019s disease to achieve reduction of arthritic manifestation (CONSIDER): phase II, randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial. Ann Rheum Dis. 2020;79(8):1090\u20137.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"3598_CR59","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1016\/S0002-9440(10)63437-2","volume":"165","author":"LR Prince","year":"2004","unstructured":"Prince LR, Allen L, Jones EC, et al. The role of interleukin-1beta in direct and toll-like receptor 4-mediated neutrophil activation and survival. Am J Pathol. 2004;165(5):1819\u201326.","journal-title":"Am J Pathol"},{"key":"3598_CR60","doi-asserted-by":"publisher","first-page":"2995","DOI":"10.3389\/fimmu.2018.02995","volume":"9","author":"RA Brown","year":"2018","unstructured":"Brown RA, Henderlight M, Do T, et al. Neutrophils from children with systemic juvenile idiopathic arthritis exhibit persistent Proinflammatory activation despite Long-Standing clinically inactive disease. Front Immunol. 2018;9:2995.","journal-title":"Front Immunol"},{"issue":"1","key":"3598_CR61","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.immuni.2008.05.012","volume":"29","author":"D Chaussabel","year":"2008","unstructured":"Chaussabel D, Quinn C, Shen J, et al. A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus. Immunity. 2008;29(1):150\u201364.","journal-title":"Immunity"},{"issue":"6","key":"3598_CR62","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1002\/art.38628","volume":"66","author":"L Chiche","year":"2014","unstructured":"Chiche L, Jourde-Chiche N, Whalen E, et al. Modular transcriptional repertoire analyses of adults with systemic lupus erythematosus reveal distinct type I and type II interferon signatures. Arthritis Rheumatol. 2014;66(6):1583\u201395.","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"3598_CR63","first-page":"477","volume":"56","author":"N Jourde-Chiche","year":"2017","unstructured":"Jourde-Chiche N, Whalen E, Gondouin B, et al. Modular transcriptional repertoire analyses identify a blood neutrophil signature as a candidate biomarker for lupus nephritis. Rheumatology (Oxford). 2017;56(3):477\u201387.","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"3598_CR64","doi-asserted-by":"publisher","first-page":"3523","DOI":"10.1038\/s41467-021-23472-7","volume":"12","author":"P Soret","year":"2021","unstructured":"Soret P, Le Dantec C, Desvaux E, et al. A new molecular classification to drive precision treatment strategies in primary sj\u00f6gren\u2019s syndrome. Nat Commun. 2021;12(1):3523.","journal-title":"Nat Commun"},{"issue":"2","key":"3598_CR65","doi-asserted-by":"publisher","first-page":"e8503","DOI":"10.15252\/msb.20188503","volume":"15","author":"D Wang","year":"2019","unstructured":"Wang D, Eraslan B, Wieland T, et al. A deep proteome and transcriptome abundance atlas of 29 healthy human tissues. Mol Syst Biol. 2019;15(2):e8503.","journal-title":"Mol Syst Biol"},{"issue":"8","key":"3598_CR66","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1016\/j.celrep.2019.10.082","volume":"29","author":"AJ Hoogendijk","year":"2019","unstructured":"Hoogendijk AJ, Pourfarzad F, Aarts CEM, et al. Dynamic Transcriptome-Proteome correlation networks reveal human myeloid differentiation and Neutrophil-Specific programming. Cell Rep. 2019;29(8):2505\u2013e194.","journal-title":"Cell Rep"},{"issue":"3","key":"3598_CR67","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1046\/j.1365-2249.2001.01626.x","volume":"125","author":"I Tikhonov","year":"2001","unstructured":"Tikhonov I, Doroshenko T, Chaly Y, Smolnikova V, Pauza CD, Voitenok N. Down-regulation of CXCR1 and CXCR2 expression on human neutrophils upon activation of whole blood by S. aureus is mediated by TNF-alpha. Clin Exp Immunol. 2001;125(3):414\u201322.","journal-title":"Clin Exp Immunol"},{"key":"3598_CR68","doi-asserted-by":"publisher","first-page":"986749","DOI":"10.3389\/fmolb.2022.986749","volume":"9","author":"S Bottini","year":"2022","unstructured":"Bottini S, Emmert-Streib F, Franco L, Editorial. AI and multi-omics for rare diseases: challenges, advances and perspectives, II. Front Mol Biosci. 2022;9:986749.","journal-title":"Front Mol Biosci"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-025-03598-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-025-03598-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-025-03598-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T10:02:47Z","timestamp":1751364167000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-025-03598-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3598"],"URL":"https:\/\/doi.org\/10.1186\/s13075-025-03598-5","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"1 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All raw data used in this study are available in a public, open-access repository and only summary-level datasets without participants were used.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"130"}}